Primary |
Hormone Replacement Therapy |
83.9% |
Hormone Therapy |
4.8% |
Oestrogen Replacement Therapy |
3.2% |
Hot Flush |
1.6% |
Hysterectomy |
1.6% |
Menopausal Symptoms |
1.6% |
Product Used For Unknown Indication |
1.6% |
Vulvovaginal Dryness |
1.6% |
|
Breast Cancer |
44.3% |
Breast Cancer Metastatic |
20.0% |
Breast Cancer In Situ |
7.1% |
Weight Increased |
5.7% |
Breast Cancer Recurrent |
2.9% |
Suicidal Ideation |
2.9% |
Urinary Tract Infection |
2.9% |
Breast Cancer Female |
1.4% |
Contralateral Breast Cancer |
1.4% |
Depression |
1.4% |
Drug Hypersensitivity |
1.4% |
Endometrial Neoplasm |
1.4% |
Necrosis |
1.4% |
Ovarian Cancer Metastatic |
1.4% |
Pruritus Generalised |
1.4% |
Thrombosis |
1.4% |
Urticaria |
1.4% |
|
Secondary |
Hormone Replacement Therapy |
79.3% |
Menopause |
4.6% |
Menopausal Symptoms |
4.3% |
Drug Use For Unknown Indication |
3.0% |
Product Used For Unknown Indication |
2.3% |
Oestrogen Replacement Therapy |
1.8% |
Emotional Distress |
0.6% |
Crohn's Disease |
0.5% |
Hypertension |
0.5% |
Osteoporosis |
0.5% |
Pain |
0.5% |
Prophylaxis |
0.5% |
Arthralgia |
0.3% |
Bipolar Disorder |
0.3% |
Delayed Puberty |
0.3% |
Hypothyroidism |
0.3% |
Acute Lymphocytic Leukaemia |
0.2% |
Asthma |
0.2% |
Bipolar I Disorder |
0.2% |
Blood Cholesterol Increased |
0.2% |
|
Breast Cancer |
39.1% |
Breast Cancer Metastatic |
38.5% |
Contralateral Breast Cancer |
2.7% |
Thrombosis |
2.5% |
Breast Cancer Recurrent |
1.7% |
Cerebrovascular Accident |
1.7% |
Breast Cancer Female |
1.4% |
Fibromyalgia |
1.4% |
Heart Rate Increased |
1.2% |
Breast Cancer In Situ |
1.0% |
Deep Vein Thrombosis |
1.0% |
Myocardial Infarction |
1.0% |
Weight Increased |
1.0% |
Hysterectomy |
0.8% |
Ovarian Cancer |
0.8% |
Ovarian Cancer Metastatic |
0.8% |
Progesterone Receptor Assay Positive |
0.8% |
Transient Ischaemic Attack |
0.8% |
Weight Decreased |
0.8% |
Pulmonary Embolism |
0.6% |
|
Concomitant |
Drug Use For Unknown Indication |
28.5% |
Product Used For Unknown Indication |
20.6% |
Rheumatoid Arthritis |
8.0% |
Depression |
5.7% |
Hypertension |
5.2% |
Pain |
4.9% |
Hormone Replacement Therapy |
3.9% |
Osteoporosis |
2.7% |
Insomnia |
2.6% |
Diabetes Mellitus |
2.3% |
Hypothyroidism |
1.9% |
Anxiety |
1.7% |
Psoriasis |
1.7% |
Blood Cholesterol Increased |
1.6% |
Crohn's Disease |
1.6% |
Gastrooesophageal Reflux Disease |
1.6% |
Restless Legs Syndrome |
1.5% |
Schizophrenia |
1.5% |
Hypersensitivity |
1.4% |
Hepatitis C |
1.3% |
|
Flushing |
8.5% |
Vomiting |
8.5% |
Weight Decreased |
8.5% |
Weight Increased |
7.3% |
Pain In Extremity |
6.1% |
Procedural Complication |
6.1% |
Depression |
4.9% |
Respiratory Failure |
4.9% |
Unevaluable Event |
4.9% |
Drug Ineffective |
3.7% |
Drug Level Increased |
3.7% |
Dyspnoea |
3.7% |
Immune System Disorder |
3.7% |
Muscle Spasms |
3.7% |
Oesophageal Perforation |
3.7% |
Paraesthesia |
3.7% |
Psoriasis |
3.7% |
Rash |
3.7% |
Rash Pruritic |
3.7% |
Renal Failure |
3.7% |
|